Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Microscopic image of an isolate from the first U.S. case of COVID-19. Photo: Smith Collection/Gado/Getty Images

The FDA granted Monday an emergency use authorization for a new coronavirus antibody test by Abbott Laboratories.

Why it matters: Companies are pushing to create antibody tests, which indicate whether a person had the coronavirus in the past, including those who were asymptomatic.

  • The company wants to ship nearly 30 million tests in May and 60 million by June, per a press release.
  • Abbott says the test can give results of 99.6% specificity and 100% sensitivity for patients tested 14 days after symptoms began.

The big picture: The Trump administration has recommended that these tests be offered as states begin to reopen some businesses so Americans can feel confident about returning to work.

  • Abbott's antibody test is its fourth coronavirus-linked emergency use authorization from the FDA.
  • Its rapid test for coronavirus infections, which produces results in just minutes, is used at the White House.

Worth noting, via Axios' Caitlin Owens: We don't actually know whether antibodies are necessarily indicative of immunity —  or how strong that immunity might be.

  • The best value here is in understanding the virus' true spread and helping the highest-risk workplaces operate more safely — not as any kind of universal, nationwide get-back-to-normal permit.

Go deeper: U.S. doubles payment for some coronavirus tests

Go deeper

Updated Oct 7, 2020 - Health

World coronavirus updates

Expand chart
Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Axios Visuals

New Zealand now has active no coronavirus cases in the community after the final six people linked to the Auckland cluster recovered, the country's Health Ministry confirmed in an email Wednesday.

The big picture: The country's second outbreak won't officially be declared closed until there have been "no new cases for two incubation periods," the ministry said. Auckland will join the rest of NZ in enjoying no domestic restrictions from late Wednesday, Prime Minister Jacinda Ardern said, declaring that NZ had "beat the virus again."

Aug 18, 2020 - World

CDC lifts travel warning as Bermuda ramps up testing to suppress coronavirus

A view of Coral Beach, Bermuda. Photo: Slim Aarons/Hulton Archive/Getty Images

The CDC has lifted its coronavirus warning against nonessential travel to Bermuda, as the island ramps up a scheme to attract foreign workers on year-long residencies and marks 57 days with no detected community spread.

Driving the news: Over half of the British Overseas Territory's population has been tested for COVID-19 since on-island capabilities were set up on March 17. Premier David Burt told Axios the strict testing has left him "confident that we are going to be able to catch any clusters before they spread."